Study IDs Predictors of Biomechanical Function in Patients With OA Undergoing Hip Replacement
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 23, 2025 -- For patients undergoing total hip arthroplasty (THA), osteoarthritis (OA) severity is the best predictor of preoperative biomechanical function, and preoperative muscle fat fraction is the best predictor of postoperative function, according to a study published online April 23 in the Journal of Orthopaedic Research.
Ryan T. Halvorson, M.D., from the University of California in San Francisco, and colleagues examined imaging factors associated with change in biomechanical function following THA. To assess hip muscle fat fraction and OA severity, 10 patients undergoing primary THA for OA were recruited prospectively and underwent preoperative magnetic resonance imaging. A Spearman's rank correlation coefficient (ρ) was used to assess relationships of muscle fat fraction and OA severity with biomechanical function.
The researchers found the strongest association between preoperative biomechanical function and OA severity (ρ = −0.68); more severe OA predicted worse biomechanical function. There was no relation between muscle fat fraction and preoperative function. The strongest association for postoperative biomechanical function was preoperative muscle fat fraction (ρ = −0.58, −0.72, and −0.59 for gluteus medius, gluteus minimus, and tensor fascia lata, respectively), with poor function predicted by worse muscle fat fraction. No association was seen between OA severity and postoperative function. There was also no association seen for muscle fat fraction with OA severity.
"While the impact of OA on biomechanical function may be alleviated with arthroplasty, preexisting muscle quality is not addressed with THA and may represent a target for patient‐specific optimization and rehabilitation," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-24 06:00
Read more

- Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility
- Trump Administration To Cut 10,000 Health and Human Services Jobs
- Trump Administration Withdraws Key ADA Documents
- 'Broken Heart Syndrome' Doubles Risk of Hospitalization
- FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A or B With or Without Inhibitors
- The United Laboratories and Novo Nordisk Announce Exclusive License Agreement for UBT251, a GLP-1/GIP/Glucagon Triple Receptor Agonist
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions